Skip to main content
. Author manuscript; available in PMC: 2016 Apr 5.
Published in final edited form as: J Immunol. 2014 Jul 25;193(5):2118–2126. doi: 10.4049/jimmunol.1400056

Figure 4. Addison’s Disease patients show strong ex-vivo T cell responses to 21-OH.

Figure 4

Ex-vivo ELISPOT assay with PBMCs from Addison’s disease patients (top panel) or healthy controls (lower panel) upon stimulation with pool of overlapping overlapping peptides spanning the full length 21-OH protein (peptide pool) or indicated peptides. Number of spots per million cells are shown on the Y axis. Results from 3 representative patients are shown. Bars represent Standard Error of the mean (SEM).